Vol 2-1 Review Article

Non-paraneoplastic Autoimmune Retinopathy

Joaquín I. Oporto1*, Antonia Mori1, Jorge Oporto2

1Facultad de Medicina, Pontificia Universidad Católica de Chile, Santiago, Chile

2Fundación Oftalmológica Los Andes, La Serena, Chile

Non-paraneoplastic autoimmune retinopathy (npAIR) is a rare non-inflammatory immune mediated disease caused by circulating autoantibodies against the retina. Its mechanisms are still not fully understood. It is characterized by bilateral, often symmetric, rapidly progressive visual loss, visual field defects and photoreceptor dysfunction. Fundoscopy is usually unaltered in the early stages, and full field electroretinogram (ERG), visual field, optical coherence tomography (OCT), fundus autofluorescence (FAF) and fluorescein angiography may help with the diagnosis. Determination of circulating antibodies is crucial, as well as ruling-out any possible malignancy with a full physical examination and complimentary exams. Early and aggressive treatment is crucial to prevent further retinal damage. More studies are needed in order to determine more accurate diagnostic criteria, better management and follow-up that could preserve visual function and even improve it.

View / Download Pdf
Vol 2-1 Mini Review Article

OdySight: Real-World Data Analysis of a Mobile Medical Application for Ophthalmology

Aniket Nikam, Hannah Lefumat, Elidia Grondin, and Vinona Bhatia*

Tilak Healthcare, 74 Rue du Faubourg Saint-Antoine, 75012 Paris, France

Digital tools for remote monitoring have revolutionized the current landscape of healthcare delivery. With the advent of smartphones and tablets, the development of mobile medical applications (apps) has created a new dimension in telemedicine. While there are a variety of “wellness apps” available to the general public, only some of them have undergone rigorous human factors testing and clinical validation and require the recommendation of a clinician to be used for remote monitoring. In this article, we specifically review the utility of a mobile medical application called OdySight, which is being recommended by ophthalmologists throughout France for patients with chronic eye diseases.

View / Download Pdf